metabolomics

Adora Tech L.L.C. develops AI/ML-driven platforms for early detection and prevention of life-threatening diseases, including GI cancers, lung cancers, PTSD, and Alzheimer's disease. The company integrates artificial intelligence, machine learning, and scientific research into disease screening platforms, collaborating with research and clinical institutions and focusing on regulatory compliance and patient outcomes.

AI/ML platform developmentbiomarker developmentclinical data integrationgut microbiome sequencingmachine learning modelingsoftware engineering for clinical integration

Arkana Therapeutics is an early-stage, Boulder-based drug discovery company developing oral small-molecule therapies for obesity and metabolic disease. Its platform draws on metabolic adaptations found in nature, such as those seen in animals that endure prolonged fasting and extreme weight fluctuations. The company has two programs: ARK-100, an oral small molecule acting on the brain to reduce calorie intake, and ARK-200, an early-development oral small molecule designed to increase energy expenditure.

drug discoveryin vitro and in vivo modelssmall molecule development

Bridging Pieces is a Certified Small Business (CAGE Code 9DF83) focused on state and federal contracts, serving local, state, and federal government agencies as well as commercial and industrial clients. It offers a one-stop-shop of contracting services including general construction, HVAC, plumbing, logistics, courier, pest control, janitorial, non-destructive testing, biotechnology/genomics, IT solutions, and website design, development, and hosting.

Automated Ultrasonic Testing (AUT)Corrosion MappingDigital Radiography (DR/RTR)liquid penetrant testing (PT)magnetic particle testing (MT)Multi-omics and genomic testingnon-destructive testing (NDT)Phased Array UT (PAUT)positive material identification (PMI)proteomicsradiographic testing (RT)Time of Flight Diffraction (TOFD)Ultrasonic Shear Waveultrasonic testing (UT)Visual Testing (VT)

Emery Pharma is a full-service Contract Research Organization (CRO) and GLP/cGMP-compliant contract research laboratory based in Alameda, California. It supports preclinical drug development with analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and general R&D and cGMP/GLP support, delivering customized solutions to fit clients' outsourcing needs.

analytical method developmentbioanalytical assaysbiologics characterizationELISA and MSD immunoassaysGC-MSGLP/cGMP compliancehigh-resolution mass spectrometryHPLC/UPLCLC-MSLC-MS/MSmethod transfermethod validationmicrobiology testingNMRproteomicsstability testing

The European Molecular Biology Laboratory (EMBL) is an intergovernmental organisation headquartered in Heidelberg, founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies. Supported by more than 30 countries, it operates six sites in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton, and Rome, employing more than 1800 people and hosting more than 110 independent research groups and service teams.

Bioinformaticschemical biologyelectron microscopyFlow CytometryGenomicshigh-throughput crystallisationimagingin vivo gene editingIT serviceslight microscopymobile laboratory servicesprotein expression and purificationproteomicsscientific instrumentation workshopsstructural biologyX-ray beamlines

From multi-omics complexity to translational insights We integrate deep immune profiling with AI-powered translational insights to reveal the mechanisms underlying health, disease and therapeutic response.Start a collaboration IMMUNASYST provides computational deep immune profiling of health and disease through multi-omics integration, combining mechanistic systems IMMUNology with the SYSTematic orchestration of intelligent AI agents - like a coordinated immune response.Our specialization runs through infectious disease, oncology, and autoimmunity — yet systems biology honors no boundaries, reaching across virtually any condition where mechanism matters.The work is collaborative by design. You bring the disease area, cohort, and clinical context. We bring systems immunology, rigorous statistics, and AI-enabled translational analysis to turn complex data into mechanistically grounded.

AI-enabled translational analysisATAC-seqbiomarker discoveryclinical trial designFlow Cytometrymanuscript writing supportmicrobiome analysismulti-omics integrationpatient stratificationproteomicsspatial omicssystems immunologytranscriptomics